Prodia Diagnostic Line Tbk vs Surya Biru Murni Acetylene Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Surya Biru Murni Acetylene Tbk. trades at Rp107 (market cap 98.57B, 709.7K 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 4.8× Surya Biru Murni Acetylene Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 709.7K). Which is the better fit depends on your goals.
| PRDL | SBMA | |
|---|---|---|
Market Cap | 470.58B | 98.57B |
Volume | 28.43M | 709.7K |
Lot | 284.34K | 7.1K |
Turnover | 7.8B | 75.4M |
Average Price | 274.19 | 106.25 |
Value | 7.8B | 75.4M |
Indicative Equilibrium Price | 270 | 105 |
Indicative Equilibrium Volume | 2.1K | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →